U.S. Physical Therapy, Inc. (USPH) Director Acquires $132,828.00 in Stock
U.S. Physical Therapy, Inc. (NYSE:USPH) Director Harry S. Chapman purchased 1,200 shares of the company’s stock in a transaction that occurred on Tuesday, December 11th. The shares were purchased at an average price of $110.69 per share, for a total transaction of $132,828.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
NYSE:USPH opened at $109.27 on Friday. The company has a market cap of $1.39 billion, a P/E ratio of 52.53, a PEG ratio of 3.81 and a beta of 1.21. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.26. U.S. Physical Therapy, Inc. has a 52-week low of $70.10 and a 52-week high of $129.65.
U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to the consensus estimate of $112.79 million. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, research analysts expect that U.S. Physical Therapy, Inc. will post 2.55 EPS for the current fiscal year.
Large investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC purchased a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $106,000. Harvest Fund Management Co. Ltd purchased a new position in U.S. Physical Therapy during the 3rd quarter worth approximately $190,000. Ibex Investors LLC purchased a new position in U.S. Physical Therapy during the 3rd quarter worth approximately $207,000. Cambridge Investment Research Advisors Inc. purchased a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $219,000. Finally, Itau Unibanco Holding S.A. purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at approximately $235,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.
A number of research analysts recently issued reports on the company. Cantor Fitzgerald raised their price target on U.S. Physical Therapy from $103.00 to $107.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. TheStreet downgraded U.S. Physical Therapy from a “b” rating to a “c+” rating in a research note on Friday, November 2nd. Four investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $113.67.
TRADEMARK VIOLATION NOTICE: “U.S. Physical Therapy, Inc. (USPH) Director Acquires $132,828.00 in Stock” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/u-s-physical-therapy-inc-usph-director-acquires-132828-00-in-stock/2689677.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Story: How Investors Use a Balance Sheet
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.